a Department of Cardiology , Aarhus University Hospital , Aarhus , Denmark.
Scand Cardiovasc J. 2019 Jun;53(3):133-140. doi: 10.1080/14017431.2019.1612086. Epub 2019 May 12.
Left atrial flutter has been reported in up to 10% of patients following pulmonary vein isolation or cardiac surgery. Left atrial flutter is typically highly symptomatic, responds poorly to medical antiarrhythmic treatment, and is often treated by catheter ablation. We aimed to investigate midterm freedom from recurrent arrhythmia after catheter ablation for left atrial flutter. . In the National Danish Ablation Registry, we identified consecutive patients, who had undergone catheter ablation for left atrial flutter between 1 January 2014 and 1 April 2017 at our centre. A total of 53 patients (median age 68 years (IQR 60-71) 37 (70%) male) were included. Forty-two patients had prior left atrial catheter ablation procedures (79%), one patient prior ablation for classic atrial flutter (2%), four patients had prior surgery for congenital heart disease (8%), and six patients (11%) had no previous cardiac intervention. Acute procedural success, defined as non-inducibility of any atrial arrhythmia, was achieved in 45 of 53 patients (85%). During midterm follow-up (mean 20 ± 12 months), 26 patients experienced an episode of recurrent atrial arrhythmia. Median EHRA-score was 3 (range 2-4) before catheter ablation and reduced to median 1 (range 1-3) evaluated at follow-up visits after three and twelve months (both < .001, Wilcoxon rank test). Left atrial flutter is preceded by catheter ablation or cardiac surgery in 89% of patients. Acute procedural success is achieved in majority of patients and ablation reduces symptoms effectively. During midterm follow-up, almost half the patients experience recurrent atrial arrhythmia.
左房扑动在肺静脉隔离或心脏手术后的患者中发生率高达 10%。左房扑动通常症状明显,对药物抗心律失常治疗反应不佳,常需导管消融治疗。我们旨在研究导管消融治疗左房扑动的中期无复发性心律失常的效果。
在丹麦国家消融登记处,我们确定了在我们中心于 2014 年 1 月 1 日至 2017 年 4 月 1 日期间接受导管消融治疗的连续患者。共有 53 例患者(中位数年龄 68 岁(IQR 60-71),37 例(70%)为男性)入选。42 例患者有既往左房导管消融术史(79%),1 例有既往经典房扑消融术史(2%),4 例有先天性心脏病手术史(8%),6 例(11%)无既往心脏介入治疗史。45 例(85%)患者达到急性程序成功,定义为任何房性心律失常均不可诱导。在中期随访(平均 20±12 个月)中,26 例患者出现复发性房性心律失常。消融前 EHRA 评分中位数为 3(范围 2-4),3 个月和 12 个月的随访评估时降至中位数 1(范围 1-3)(均 < 0.001,Wilcoxon 秩和检验)。
左房扑动在 89%的患者中是在导管消融或心脏手术后发生的。大多数患者可实现急性程序成功,且消融可有效减轻症状。在中期随访期间,近一半的患者出现复发性房性心律失常。